Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience Read More > January 22, 2016
Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-NN-dimethyltryptamine Read More > January 15, 2016
Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights. Read More > January 12, 2016
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression Read More > January 11, 2016
Genotoxic evaluations in Wistar rats of the hallucinogenic plant extract ayahuasca Read More > January 1, 2016
As Molly Takes The Party Toll: MDMA Toxicity Presenting With Pulmonary Hemorrhage Read More > January 1, 2016
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent Read More > January 1, 2016
Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats Read More > December 30, 2015
